LincRNA ZNF529-AS1 inhibits hepatocellular carcinoma via FBXO31 and predicts the prognosis of hepatocellular carcinoma patients

[1] Shangguan D(2008)Identification of liver cancer-specific aptamers using whole live cells Anal Chem 80 721-728

[2] Meng L(2017)Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups Hepatology (Baltimore, MD) 65 104-121

[3] Cao ZC(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249

[4] Xiao Z(2015)The evolving epidemiology of hepatocellular carcinoma: a global perspective Expert Rev Gastroenterol Hepatol 9 765-779

[5] Fang X(2021)Epidemiology and risk-stratification of NAFLD-associated HCC J Hepatol 75 1476-1484

[6] Li Y(2022)BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update J Hepatol 76 681-693

[7] Cardona D(2019)Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China JAMA Surg 154 209-217

[8] Witek RP(2020)Liver transplantation for hepatocellular carcinoma: management after the transplant Am J Transplant 20 333-347

[9] Liu C(2022)Emerging insights on immunotherapy in liver cancer Antioxid Redox Signal 108 e21830-185

[10] Tan W(2021)Identification of an Arch Insect Biochem Physiol 10 444-3069

[1] Shangguan D(2008)Identification of liver cancer-specific aptamers using whole live cells Anal Chem 80 721-728

[2] Meng L(2017)Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups Hepatology (Baltimore, MD) 65 104-121

[3] Cao ZC(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249

[4] Xiao Z(2015)The evolving epidemiology of hepatocellular carcinoma: a global perspective Expert Rev Gastroenterol Hepatol 9 765-779

[5] Fang X(2021)Epidemiology and risk-stratification of NAFLD-associated HCC J Hepatol 75 1476-1484

[6] Li Y(2022)BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update J Hepatol 76 681-693

[7] Cardona D(2019)Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China JAMA Surg 154 209-217

[8] Witek RP(2020)Liver transplantation for hepatocellular carcinoma: management after the transplant Am J Transplant 20 333-347

[9] Liu C(2022)Emerging insights on immunotherapy in liver cancer Antioxid Redox Signal 108 e21830-185

[10] Tan W(2021)Identification of an Arch Insect Biochem Physiol 10 444-3069